| pubmed-article:15641102 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0039103 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0025677 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C2825032 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0332287 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0666743 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
| pubmed-article:15641102 | lifeskim:mentions | umls-concept:C1883709 | lld:lifeskim |
| pubmed-article:15641102 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15641102 | pubmed:dateCreated | 2005-1-13 | lld:pubmed |
| pubmed-article:15641102 | pubmed:abstractText | Anti-tumor necrosis factor alpha agents are among the most effective therapies for rheumatoid arthritis (RA). However, their optimal use is yet to be determined. This 12-month double-blind study attempted remission induction using standard therapy with or without infliximab in patients with early, poor-prognosis RA. The primary end point was synovitis (measured by magnetic resonance imaging [MRI]). Clinical observations continued to 24 months. | lld:pubmed |
| pubmed-article:15641102 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15641102 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641102 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15641102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641102 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15641102 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:15641102 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:EmeryPaulP | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:ConaghanPhili... | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:QuinnMark AMA | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:KarimZunaidZ | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:BrownAndrewA | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:BrownClareC | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:FraserAlexand... | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:O'ConnorPhili... | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:GreensteinAda... | lld:pubmed |
| pubmed-article:15641102 | pubmed:author | pubmed-author:JarretStephen... | lld:pubmed |
| pubmed-article:15641102 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15641102 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:15641102 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15641102 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15641102 | pubmed:pagination | 27-35 | lld:pubmed |
| pubmed-article:15641102 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:meshHeading | pubmed-meshheading:15641102... | lld:pubmed |
| pubmed-article:15641102 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15641102 | pubmed:articleTitle | Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. | lld:pubmed |
| pubmed-article:15641102 | pubmed:affiliation | Academic Unit of Musculoskeletal Disease, First Floor, Leeds General Infirmary, Great George Street, Leeds LS1 3EX, UK. | lld:pubmed |
| pubmed-article:15641102 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15641102 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15641102 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15641102 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641102 | lld:pubmed |
